Trials / Completed
CompletedNCT04296825
Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus
Effect of Camel Milk Containing Bifidobacterium Animalis A6 on Chinese People With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- China Agricultural University · Academic / Other
- Sex
- All
- Age
- 35 Years – 68 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effects of dietary supplement with Camel Milk containing Bifidobacterium animalis A6 on the plasma glucose and other related cytokines in patients with type 2 diabetes mellitus. 45 patients with type 2 diabetes mellitus were recruited, and a Double Blind Randomized Parallel Controlled Trial was performed. The fasting glycaemia, 2 hour postprandial glycaemia, insulin, uric acid and serum lipid (total cholesterol, total triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol ) were measured as Primary Outcome. The Fecal microbiome, fecal metabolites, gut hormones (amylin, ghrelin, glucagon-like peptide 1, pancreatic polypeptide), inflammation cytokines (TNF-α, IL-6, MCP-1), myokines (FGF-21, irisin, osteocrin/musclin, osteonectin) and adipokines (adiponectin, resistin, lipocalin-2, adipsin) and body composition analysis were also assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Camel milk containing Bifidobacterium animalis A6 | Take the interventions about 30 minutes after meals in the morning and evening for 4 consecutive weeks. |
| DIETARY_SUPPLEMENT | Camel milk | Take the interventions about 30 minutes after meals in the morning and evening for 4 consecutive weeks. |
| DIETARY_SUPPLEMENT | Bifidobacterium animalis A6 | Take the interventions about 30 minutes after meals in the morning and evening for 4 consecutive weeks. |
| DIETARY_SUPPLEMENT | Cow milk | Take the interventions about 30 minutes after meals in the morning and evening for 4 consecutive weeks. |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-06-09
- Completion
- 2018-07-09
- First posted
- 2020-03-05
- Last updated
- 2020-03-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04296825. Inclusion in this directory is not an endorsement.